Lancet Microbe
Scope & Guideline
Connecting Science and Solutions in Microbiology
Introduction
Aims and Scopes
- Infectious Disease Epidemiology:
The journal publishes research that investigates the patterns, causes, and effects of infectious diseases in populations, utilizing statistical models and epidemiological frameworks. - Microbial Genomics:
There is a significant focus on genomic studies that explore the genetic basis of pathogen virulence, antibiotic resistance, and the evolution of microbial populations. - Antimicrobial Resistance (AMR) Studies:
Lancet Microbe places a strong emphasis on research related to the emergence and spread of antimicrobial resistance, including surveillance studies and the development of novel therapeutic strategies. - One Health Approach:
The journal promotes interdisciplinary research that connects human, animal, and environmental health, highlighting the interconnectedness of infectious disease dynamics. - Innovative Diagnostic Techniques:
Research on new diagnostic methods, including molecular and genomic techniques, is a core area, aiming to improve the detection and management of infectious diseases. - Clinical Trials and Therapeutics:
The journal features studies assessing the efficacy and safety of vaccines and therapeutics for various infectious diseases, particularly in response to emerging health threats.
Trending and Emerging
- COVID-19 Research:
Research related to COVID-19 remains a dominant theme, with a focus on vaccine efficacy, long-term effects, and the dynamics of variants, as the pandemic continues to influence public health priorities. - Microbiome Studies:
There is a growing interest in the role of the microbiome in health and disease, particularly its interaction with infectious agents and its impact on treatment outcomes. - Zoonotic Disease Surveillance:
Studies addressing zoonotic diseases, particularly in the context of environmental changes and human-animal interactions, are increasingly prevalent, reflecting concerns over emerging infectious diseases. - Antimicrobial Stewardship Programs:
Research focused on strategies for optimizing antimicrobial use and combating resistance through stewardship initiatives is gaining traction, highlighting the need for responsible antibiotic usage. - Global Health Equity and Access to Care:
Emerging themes emphasize the importance of equitable access to healthcare and vaccines, particularly in low- and middle-income countries, as part of a comprehensive response to infectious diseases.
Declining or Waning
- Traditional Antibiotic Development:
Research specifically focused on traditional antibiotic development seems to be waning, possibly due to a growing emphasis on alternative therapies and the need for more innovative approaches to combat antibiotic resistance. - Single Pathogen Studies:
There is a noticeable decline in studies focusing solely on individual pathogens without considering broader microbial interactions or community dynamics, indicating a shift towards more holistic approaches. - Non-Genomic Surveillance Techniques:
As genomic technologies and molecular techniques gain prominence, traditional surveillance methods that do not incorporate genomic data are becoming less frequently reported in the literature. - In-depth Studies on Established Vaccines:
Research centered on well-established vaccines is less prevalent, as there is a greater focus on novel vaccine development and the response to emerging pathogens.
Similar Journals
Microorganisms
Unveiling the mysteries of microbial life.Microorganisms is a leading open-access journal published by MDPI based in Switzerland, catering specifically to the rapidly evolving fields of microbiology and virology. Since its inception in 2013, the journal aims to foster the dissemination of high-quality research through its comprehensive and interdisciplinary platform, with a particular focus on both fundamental and applied microbiological sciences. Contributing to its esteemed reputation, Microorganisms holds a commendable Q2 ranking in the categories of Microbiology and Virology, as well as in Medical Microbiology, highlighting its significance in the academic community. With a consistent impact, evidenced by its rankings in Scopus—such as rank #25 in Virology and #56 in Microbiology—the journal serves as an invaluable resource for researchers, professionals, and students looking to stay at the forefront of microbiological research. As an open-access journal, Microorganisms ensures that vital research findings are readily available to a global audience, promoting collaboration and innovation in the study of microbial life and its implications for health and disease.
Antibiotics-Basel
Pioneering discoveries in antibiotic management and resistance.Antibiotics-Basel is a prestigious multidisciplinary journal published by MDPI, dedicated to advancing the field of antibiotic research and management. Since its inception in 2012 as an Open Access publication, the journal has established itself as a vital resource for researchers and professionals, offering an accessible platform for the dissemination of innovative findings in Biochemistry, Infectious Diseases, Microbiology, and Pharmacology. With a solid impact in its category, Antibiotics-Basel holds a Q1 ranking in critical areas such as Pharmacology and Pharmacology, Toxicology and Pharmaceutics, making it an influential journal in its field. The journal publishes high-quality research articles, reviews, and communications that are essential for advancing our understanding of antibiotic mechanisms, resistance, and therapeutic applications. Researchers are invited to submit their manuscript to contribute to this growing body of knowledge and collaborate in the fight against antibiotic resistance and infectious diseases.
Microbiology Australia
Exploring the Frontiers of Microbial ScienceMicrobiology Australia is a prominent journal published by CSIRO PUBLISHING, focusing on the diverse and rapidly evolving field of microbiology. Since its transition to Open Access in 2021, it has broadened its accessibility, fostering greater dissemination of research findings among scholars and practitioners. The journal features a range of topics that are pivotal for understanding microbial systems in applied microbiology, medical microbiology, public health, and environmental applications. Despite its current categorization in the Q4 quartile across several categories, it remains an essential platform for emerging research and innovative methodologies. Researchers and professionals can benefit from the journal's commitment to enriching the global discourse on microbiological advancements. With its ISSN 1324-4272 and E-ISSN 2201-9189, Microbiology Australia caters to a wide audience in Australia and beyond, making significant strides in bridging the gap between research and practical applications in microbiology.
BRAZILIAN JOURNAL OF MICROBIOLOGY
Exploring the Microbial World for a Healthier TomorrowThe BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.
MIKROBIYOLOJI BULTENI
Advancing the Frontiers of MicrobiologyMIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.
Southern African Journal of Infectious Diseases
Enhancing accessibility to essential health research.Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.
BMC MICROBIOLOGY
Pioneering discoveries in microbiology, accessible to all.BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.
TRENDS IN MICROBIOLOGY
Leading the Charge in High-Impact Microbial ResearchTRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.
New Microbes and New Infections
Connecting global researchers to combat new infections.New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.
Annals of Clinical Microbiology and Antimicrobials
Empowering researchers with open access to groundbreaking studies.Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.